| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Natus Medical (NASDAQ:NTUS) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:01 PM.
Here's what investors need to know about the announcement.
Natus Medical beat estimated earnings by 6.82%, reporting an EPS of $0.47 versus an estimate of $0.44.
Revenue was up $9.94 million from the same period last year.
Last quarter the company missed on EPS by $0.06 which was followed by a 5.98% increase in the share price the next day.
Here's a look at Natus Medical's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | 0.34 | 0.25 | 0.16 | 0.24 |
| EPS Actual | 0.28 | 0.29 | 0.16 | 0.39 |
| Revenue Estimate | 116.80M | 114.00M | 111.40M | 110.00M |
| Revenue Actual | 113.88M | 115.98M | 114.93M | 118.72M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: NTUS
